BriefScience

CRISPR’s Ability to Knock Down RNA May Be Artificially Inflated

·1h ago
Share:PostShare

CRISPR’s Ability to Knock Down RNA May Be Artificially Inflated

N

Newsbreak

Original source

Read full story

Related Stories

Science13h ago

Twist Bioscience to Present at Baird 2026 Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that Emily M. Leproust, Ph.D., CEO and co-founder of Twist Bioscience, and Adam Laponis, CFO of Twist Bioscience, will participate in a fireside chat at the Baird 2026 Global Healthcare Conference on Tuesday, September 15, 2026 at 1:25 pm Eastern Time in New York City. The fireside chat will be webcast live and can be accessed by visiting the “In

BBusinesswire

Headlines and briefs on this site are for information only. Always verify details on the original source or live status page.

Read Disclaimer